A need for biology-driven personalized radiotherapy in breast cancer

被引：4
|
作者：
Tsoutsou, Pelagia G. [1 ,2 ,3 ]
Durham, Andre-Dante [2 ,3 ]
Vozenin, Marie-Catherine [2 ,3 ]
机构：
[1] Hop Neuchatelois, Dept Radiat Oncol, Rue Chasseral 20, CH-2300 La Chaux De Fonds, Switzerland
[2] CHU Vaudois, Div Oncol, Radiooncol Dept, Rue Bugnon 46, CH-1011 Lausanne, Switzerland
[3] CHU Vaudois, Radiooncol Res Lab, Biopole 3-9A Rue Corniche, CH-1066 Lausanne, Switzerland
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2018年 / 167卷 / 02期
关键词：
RECEPTOR; THERAPY; RADIATION; CELLS; RISK;
D O I：
10.1007/s10549-017-4522-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：603 / 604
页数：2
相关论文
共 50 条
  • [31] Can personalized treatment reduce cardiotoxicity in left breast cancer radiotherapy?
    Cima, S.
    Valli, M. C.
    Frapolli, M.
    Nicolini, G.
    Azinwi, N.
    Presilla, S.
    Richetti, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S48 - S49
  • [32] 'Personalized scheduling' of radiotherapy for patients with breast cancer might reduce toxicity
    不详
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2018, 79 (12) : 671 - 671
  • [33] A Biology-Driven Deep-Learning Based Cell Survival Model for Proton Radiation
    Lai, Y.
    Shen, C.
    Chi, Y.
    Guan, F.
    Jia, X.
    [J]. MEDICAL PHYSICS, 2021, 48 (06)
  • [34] Personalized medicine approaches for colon cancer driven by genomics and systems biology: OncoTrack
    Henderson, David
    Ogilvie, Lesley A.
    Hoyle, Nicholas
    Keilholz, Ulrich
    Lange, Bodo
    Lehrach, Hans
    [J]. BIOTECHNOLOGY JOURNAL, 2014, 9 (09) : 1104 - 1114
  • [35] Estimating the need for palliative radiotherapy for breast cancer: A benchmarking approach
    Jin, C. J.
    Kong, W.
    Mackillop, W. J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S314 - S314
  • [36] MR-Driven Radiotherapy of Prostate Cancer Patients, a Need for Speed
    Persson, E.
    Gustafsson, C.
    Jonsson, J.
    Ceberg, S.
    Gunnlaugsson, A.
    Olsson, L. E.
    [J]. MEDICAL PHYSICS, 2018, 45 (06) : E619 - E619
  • [37] A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients
    Paolo Fardin
    Annalisa Barla
    Sofia Mosci
    Lorenzo Rosasco
    Alessandro Verri
    Rogier Versteeg
    Huib N Caron
    Jan J Molenaar
    Ingrid Øra
    Alessandra Eva
    Maura Puppo
    Luigi Varesio
    [J]. Molecular Cancer, 9
  • [38] A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients
    Fardin, Paolo
    Barla, Annalisa
    Mosci, Sofia
    Rosasco, Lorenzo
    Verri, Alessandro
    Versteeg, Rogier
    Caron, Huib N.
    Molenaar, Jan J.
    Ora, Ingrid
    Eva, Alessandra
    Puppo, Maura
    Varesio, Luigi
    [J]. MOLECULAR CANCER, 2010, 9
  • [39] Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach
    Isidori, Alessandro
    Loscocco, Federica
    Ciciarello, Marilena
    Corradi, Giulia
    Lecciso, Mariangela
    Ocadlikova, Darina
    Parisi, Sarah
    Salvestrini, Valentina
    Amadori, Sergio
    Visani, Giuseppe
    Curti, Antonio
    [J]. CANCERS, 2018, 10 (07)
  • [40] Biology-driven clustering of microarray data - Applications to the NC160 data set
    Coombes, KR
    Baggerly, KA
    Stivers, DN
    Wang, J
    Gold, D
    Sung, HG
    Lee, SJ
    [J]. METHODS OF MICROARRAY DATA ANALYSIS II, 2002, : 65 - 79
12345